Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK.

Immunity | 2011

Tight regulation of NF-κB signaling is essential for innate and adaptive immune responses, yet the molecular mechanisms responsible for its negative regulation are not completely understood. Here, we report that NLRX1, a NOD-like receptor family member, negatively regulates Toll-like receptor-mediated NF-κB activation. NLRX1 interacts with TRAF6 or IκB kinase (IKK) in an activation signal-dependent fashion. Upon LPS stimulation, NLRX1 is rapidly ubiquitinated, disassociates from TRAF6, and then binds to the IKK complex, resulting in inhibition of IKKα and IKKβ phosphorylation and NF-κB activation. Knockdown of NLRX1 in various cell types markedly enhances IKK phosphorylation and the production of NF-κB-responsive cytokines after LPS stimulation. We further provide in vivo evidence that NLRX1 knockdown in mice markedly enhances susceptibility to LPS-induced septic shock and plasma IL-6 level. Our study identifies a previously unrecognized role for NLRX1 in the negative regulation of TLR-induced NF-κB activation by dynamically interacting with TRAF6 and the IKK complex.

Pubmed ID: 21703539 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA121191-05
  • Agency: NCI NIH HHS, United States
    Id: R01 CA090327-09
  • Agency: NCI NIH HHS, United States
    Id: R01 CA116408
  • Agency: NCI NIH HHS, United States
    Id: R01 CA121191
  • Agency: NCI NIH HHS, United States
    Id: P50 CA126752
  • Agency: NCI NIH HHS, United States
    Id: R01 CA090327
  • Agency: NCI NIH HHS, United States
    Id: P50 CA126752-05
  • Agency: NCI NIH HHS, United States
    Id: R01 CA101795
  • Agency: NCI NIH HHS, United States
    Id: P01 CA094237
  • Agency: NCI NIH HHS, United States
    Id: R01 CA116408-05
  • Agency: NCI NIH HHS, United States
    Id: P01 CA094237-10
  • Agency: NCI NIH HHS, United States
    Id: R01 CA101795-05

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Cell Signaling Technology (tool)

RRID:SCR_004431

Privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study cell signaling pathways that impact human health.

View all literature mentions